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Abstract
The quantitative characterisation of the solid form of drug substances and drug products is gaining importance due to product
quality and performance that is based on stringent regulatory guidelines. Therefore, in this study, thermal, X-ray diffraction and
spectroscopic methods were evaluated to obtain a simple, quick and precise method for the quantitative analysis of binary mixtures
of eletriptan hydrobromide polymorphs in powder form. The two polymorphs are discernible using differential scanning calorimetry
(DSC), powder X-ray diffraction (PXRD) and diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS). Quantitative
methods using each technique were developed and validated using spiked standards prepared by geometrical mixing of the pure
polymorphs. The estimated limit of detection values of the methods using DSC, PXRD and DRIFTS were determined to be 0.24%,
2.01% and 2.06%, respectively. A careful evaluation of the validation results from the three methods indicated that DSC performed
better than PXRD and DRIFTS. The DSC method was determined to be the best alternative to PXRD and DRIFTS due to its
measurement capability, simplicity, cost effectiveness and quickness. The real-time sample batch analysis was performed, and the
advantages and applications of the study are discussed.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Polymorphism occurs when a pure chemical com-
pound exists in two or more structural orientation with
different physical properties. Because different poly-
morphs exhibit different physical properties, such as
density, melting point and solubility, polymorph charac-
terisation is important in the manufacture of chemicals,
especially pharmaceuticals. The production of redundantbehalf of Taibah University. This is an open access article under the
or impure polymorphs yields a product that is not useful
for the desired purpose. Identification and quantification
of polymorphic forms is required in the production of
pharmaceuticals [1,2]. Various problems may arise due
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were scanned in the selected range using the instru-
mental parameters mentioned in the PXRD analysis.Fig. 1. Molecular structure of eletriptan hydrobromide.
o the differences in the flow properties, compatibility,
rystal morphology, water uptake properties and pro-
essability of the different forms [3,4]. The appearance
r disappearance of a redundant crystalline form during
rocess development can lead to detrimental results dur-
ng manufacturing or storage of the dosage form [5–7].
herefore, the polymorphs need to be characterised dur-
ng the beginning stage of drug development [8].
Many techniques are available for the analysis and
uantification of polymorphic mixtures. Powder X-ray
iffraction [9,10], diffuse reflectance infrared spec-
roscopy [11,12], Raman spectroscopy [13–15] and
ifferential scanning calorimetric [16,9] have been
xtensively used to quantify polymorphic mixtures with
ethods ranging from univariate correlations to multi-
ariate chemometric approaches.
A migraine is a neurovascular headache, and
igraines are characterised by recurrent headaches that
ypically last from 4 to 72 h. Simple analgesics and non-
teroidal anti-inflammatory drugs are useful if taken
t the earliest signs of the attack. Eletriptan hydrobro-
ide, which is intended for the treatment of migraine
eadaches, is known to exist as   and -polymorphs.
ttacks not responding to simple analgesics or non-
teroidal anti-inflammatory drugs may be treated with
elective serotonin (5HT1) agonists, such as eletriptan
17,18] (Fig. 1).
The crystal structures of eletriptan   and   poly-
orphs have been reported, and the polymorphs exhibit
onformational polymorphism where the   form is less
table than the   form [19]. To the best of our knowl-
dge, no efforts have been made to quantify the   and
 mixtures of eletriptan. In this study, a quantification
odel for binary mixtures was developed using DSC,
XRD and DRIFTS, and the advantage of DSC over
XRD and DRIFTS are discussed based on the results
rom a real sample.iversity for Science 9 (2015) 586–593 587
2.  Materials  and  methods
Eletriptan - and -polymorphs were obtained
from PharmaTrain (Hyderabad, India) and confirmed
using DSC, PXRD and DRIFTS. The eletriptan 
and -polymorphs and their required concentrations
for quantification using DSC, PXRD and DRIFT
were prepared by accurately weighing the mate-
rial on highly sensitive microbalances (i.e., Mettler
Toledo XP2U, Max 2.1 g-Min 1 g and Mettler
Toledo MX5, Max 5.1 g-Min 1 g). Potassium bro-
mide (KBr) was obtained from Merck (Darmstadt,
Germany).
2.1.  Differential  scanning  calorimetry  (DSC)
A Mettler Toledo DSC 831e with the STARe soft-
ware was used for recording and processing the DSC
thermograms of the eletriptan   and -polymorphs. To
identify and quantify the two forms, approximately 5 mg
of the individual polymorphs and their mixtures were
accurately weighed and heated in a closed aluminium
pan at a programmed heating rate of 25 ◦C/min in a tem-
perature range from 100 ◦C to 210 ◦C under a nitrogen
flow at 40 ml/min. An empty aluminium pan was used
as a reference.
2.2.  X-ray  powder  diffraction  (XRD)  analysis
The X-ray powder diffraction patterns were col-
lected at room temperature on a Bruker D8 advance
X-ray diffractometer with a Cu anode and Lynx eye
detector. The instrument was calibrated for the peak posi-
tion and relative intensity using the Corundum standard
(i.e., NIST traceable, standard reference material num-
ber 1976a). To identify the polymorphs, the eletriptan
 and  polymorphs were scanned from 3◦ 2θ  to 45◦
2θ  with step size of 0.01◦ 2θ  and a time per step
of 0.1 s. After selecting the non-interfering peak for
quantification, the patterns were collected from 5◦ 2θ
to 10◦ 2θ  with step size of 0.01◦ 2θ  and a time per
step of 0.9 s. The instrument was operated at a gen-
erator voltage of 40 kV and a generator current of
40 mA. A variable divergent slit and an anti-scattering
slit were used for V20 mm, and a nickel filter was used
in the secondary beam path. The spiked concentrationsThe Eva software was used for data processing and
evaluation.
ibah University for Science 9 (2015) 586–593588 P. Kommavarapu et al. / Journal of Ta
2.3.  Diffuse  reﬂectance  infrared  Fourier
transformed  spectroscopic  (DRIFTS)  measurements
The DRIFT spectra of the drug powder were recorded
at room temperature in a range of 4000–400 cm−1 using
a Perkin–Elmer Spectrum 100 with a diffuse reflectance
sampling accessory. Diluted sample mixtures were pre-
pared by mixing the drug powder with spectroscopy
grade KBr. The sample mixtures were well ground prior
to the measurements to prepared homogenous samples
and increase the relative reflectance from the samples.
The serial dilution method was used to prepare the poly-
morphic mixtures consisting of the   and   forms of
eletriptan. Diluted premixed samples of the   and 
forms of eletriptan in KBr were prepared, and then, the
required concentrations of these samples were prepared
for quantification. The sample mixtures were placed in a
small sample cup and placed on the sample holder. The
spectra were recorded with a resolution of 4.0 cm−1, and
16 scans were collected for each spectrum. The back-
ground spectra were obtained with ground KBr powder
for each experimental condition. Spectroscopic manip-
ulation, such as smoothing and normalisation, were
performed using software.
2.4.  Method  validation
The method validation was included to verify and
determine the following parameters: specificity, linear-
ity, accuracy, precision, limit of detection (LOD) and
limit of quantification (LOQ).
2.4.1. Speciﬁcity
Specificity is the ability to measure a specific ana-
lyte free from interference of other components. In this
case, the PXRD, DSC and DRIFTS were able to clearly
identify the   and   forms of eletriptan.
2.4.2. Linearity,  LOD  and  LOQ
Linearity is defined as a direct and proportional
response to changes in the concentration. The linearity
was studied by analysing the standard spiked concen-
trations of the  and   forms of eletriptan in the range
of 0.24–11.0% for DSC and 2.0–20.0% for PXRD and
DRIFTS. The LOD was determined by visual evaluation
(i.e., the detection limit is determined by the analysis
of samples with known concentrations of analyte and
establishing the minimum level at which the analyte can
be reliably detected). For the LOQ concentration, the
3 X LOD concentration is taken, and the quantitation
limit is determined based on the analysis of samples
with known concentrations of analyte and establishingFig. 2. Overlaid DSC thermograms of eletriptan  and -polymorphs.
the minimum level at which the analyte can be quantified
with acceptable accuracy and precision.
2.4.3. Accuracy  and  precision
The accuracy is calculated as the percentage of recov-
ery by the addition of the known added amount of analyte
in the sample using a minimum of nine determinations
over a minimum of three concentration levels (i.e., three
concentrations and three replicates of each concentra-
tion). The spiked concentrations of the   and  forms of
eletriptan were approximately 0.3%, 0.6% and 0.9% for
DSC and 3%, 6% and 9% for the PXRD and DRIFTS
experiments.
The precision of an analytical method is the degree
of agreement among individual test results when the
method is applied repeatedly to multiple samplings of
a homogeneous sample. The precision of this analytical
method is expressed as the relative standard deviation
(coefficient of variation) of a series of measurements. Six
spiked concentrations of the   and   forms of eletriptan
were prepared at the LOQ level and analysed using DSC,
PXRD and DRIFTS.
3.  Results  and  discussion
3.1.  Characterisation  of  eletriptan  polymorphs
The crystal forms of eletriptan hydrobromide (Alpha
form and Beta form) were characterised by DSC (Fig. 2),
PXRD (Fig. 4) and DRIFTS (Fig. 8).All three methods identified the eletriptan poly-
morphs and can be used for the qualitative determination
of the two polymorphs. Further evaluation of each
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ethod was necessary to determine the best technique
or the quantification of the polymorphs of eletriptan.
.2.  Differential  scanning  calorimetry
The melting point of alpha form of eletriptan is in the
69–186 ◦C range. The melting range of the beta form of
letriptan is 147–165 ◦C. The LOD and LOQ values were
etermined to be 0.24% and 0.58%, respectively. For the
ifferent spiked sample concentrations of the alpha and
eta forms of eletriptan (i.e., 0.24%, 0.58%, 2.5%, 4.4%,
.6% and 11.0% w/w), the differential normalised heat
ow values were determined to be 0.065 Jg−1, 0.12 Jg−1,
.17 Jg−1, 2.21 Jg−1, 3.97 Jg−1 and 5.81 Jg−1, respec-
ively. The overlay of the spiked concentrations is shown
n Fig. 3. The calibration plot exhibited good linear-
ty over the entire concentration range with a high
ig. 4. Overlaid PXRD profiles of eletriptan  and -polymorphs.f the spiked concentrations.
correlation (r2) of 0.9996, and the linear regression
equation was determined to be y = 0.5406x–0.1417. The
linearity plot is shown in Fig. 5. The % recovery at
the LOQ level was in the 98–105% range. Six spiked
concentrations at the LOQ level were scanned, and the
relative standard deviation was determined to be 4.1%.
The low %RSD indicates that the method is precise and
reproducible.
3.3.  Powder  X-ray  diffraction  (PXRD)
The diffraction patterns of the   and   forms of
eletriptan exhibit characteristic peaks, as shown in
Table 1. Therefore, the non-interfering peak for the beta
form of eletriptan was selected to be at 5.408◦ 2θ  for
quantification purposes, and therefore, the method is spe-
cific. For different spiked sample concentrations of the
y = 0.5406 x - 0.147 1
R² = 0.999 6
-1
0
1
2
3
4
5
6
7
0 2 4 6 8 10 12
N
or
m
al
iz
ed
He
at
Fl
ow
Spiked concent raon s
DSC Linearity Plot
Fig. 5. linearity plot for the spiked concentrations of eletriptan -
polymorph in -polymorphs using DSC.
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Table 1
Characteristic peaks of eletriptan polymorphs using X-ray diffraction
technique.
Eletriptan -form Eletriptan -form
Angle (2) Intensity % Angle (2) Intensity %
9.491 15.7 5.408 15.6
10.141 6.3 8.706 2.8
10.485 37 10.789 91.3
12.085 7.1 12.017 6.6
12.715 7.6 12.232 5.4
15.007 8.1 12.632 17.1
15.695 53 13.04 17.2
16.096 16.3 15.15 9.8
16.303 30.7 15.487 16.3
16.799 16.5 16.238 14.4
17.551 23.4 16.706 18.9
18.032 37.8 16.972 19.9
18.262 36.6 17.407 34.6
19.025 27.1 17.877 48.1
19.252 50.4 18.96 24.1
19.587 61.1 19.283 30
19.88 28.5 19.754 33.1
20.457 100 19.911 51.6
21.005 14.1 21.023 11.7
21.435 26.9 21.25 28.1
y = 0.0199 x + 0.003 7
R² = 0.998 4
0
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PXRD Linearity Plot21.825 18.5 21.457 28.6
22.055 34.5 21.81 30.1
  and   forms of eletriptan (i.e., 2.01%, 6.04%, 7.95%,
9.91%, 15.01% and 19.97% w/w), the net areas were
determined to be to be 0.051 Cps X 2θ◦, 0.121 Cps X
2θ◦, 0.158 Cps X 2θ◦, 0.194 Cps X 2θ◦, 0.305 Cps X
2θ◦, 0.403 Cps X 2θ◦, respectively. The overlaid diffrac-
tion pattern of the spiked concentrations is shown in
Fig. 6. The LOD and LOQ using PXRD technique were
2.06% w/w and 6.09% w/w, respectively. The correla-
tion (r2) was 0.9983, and the linear regression equation
was determined to be y = 0.02x  + 0.0018. The linearity
plot is shown in Fig. 7. The % recovery at the LOQ level
Fig. 6. Overlaid PXRD profiles of eletriptan spiked concentrations.Fig. 7. linearity plot for the spiked concentrations of eletriptan -
polymorph in -polymorphs using PXRD.
was in the 98–102% range. Six spiked concentrations at
the LOQ level were scanned, and the relative standard
deviation was determined to be 2.1%.
3.4.  Diffuse  reﬂectance  infrared  Fourier  transform
spectroscopy  (DRIFTS)
The two polymorphic mixtures of eletriptan were
characterised by DRIFTS, as shown in Fig. 8. The poly-
morphs exhibit distinct vibrational frequencies that may
be used for identification. The wavenumbers of the bands
for the  and   polymorphs of eletriptan are consistent
with the literature data. For the alpha form, the absorption
bands were located at approximately   = 3371, 3293,
2713, 2524, 1419, 1343, 1307, 1264, 1151, 1086, 1020,
1008, 999, 922, 900, 805, 758, 740, 728, 689, 672, 652,
640, 598, 581, 573, 531, 498, 465, 457, 443, 428, 422,
414 and 399 cm−1. In addition, the absorption bands for
the beta form were located at approximately   = 3239,
2672, 2656, 2632, 1409, 1366, 1351, 1334, 1303, 1293,
1152, 1138, 1122, 1098, 1086, 791, 771, 746, 688, 634,
557, 528, 484, 476, 469, 463, 455, 432, 424, 413and
Fig. 8. Overlaid DRIFT spectra of eletriptan  and -polymorphs.
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Application of the method was demonstrated by
performing real sample analysis of eleven batches ofFig. 10. Plot of Specified concentration versus residual.
01 cm−1 [20]. The most prominent differences are
ocated at 557.0 cm−1, 769.2 cm−1, 1123.2 cm−1 and
409.1 cm−1. A unique peak for the beta form was
ocated at approximately 776.12–788.19 cm−1, and this
eak is free from spectral overlap. Therefore, this peak
s appropriate for univariate calibration. The quantita-
ive application of DRIFT is based on the application of
eer’s law, which relates the intensity of the absorbance
r intensity of a characteristic peak to an inert peak to the
er cent concentration of one of the polymorphic mix-
ures. The overlaid DRIFT spectra are shown in Fig. 9.
ased on the spectral data collected with this measure-
ent procedure, the residuals were randomly distributed
round zero (Fig. 10), and a good linear correlation (r2)
f 0.9947 was obtained for the specified concentrations
w/w) compared to the calculated concentrations (w/w)
Fig. 11). The % recovery at the LOQ level was in the
7–105% range. Six spiked concentrations at the LOQ
evel were scanned, and the relative standard deviation
as determined to be 3.3%.Fig. 11. Linearity plot of specified concentrations versus calculated
concentrations.
3.5.  Comparison  of  the  three  techniques
Binary polymorphic mixtures of eletriptan have been
prepared and quantitatively analysed using DSC, PXRD
and DRIFTS with univariate analysis. The results were
accurate and reproducible for the quantitative measure-
ment of the beta form in alpha form (Table 2) using
these techniques. To test the applicability and accuracy
of DSC for determining the polymorphic content, sev-
eral test mixtures were analysed in triplicate using the
DSC method, and the results from this method were
compared to those obtained with the PXRD and DRIFTS
methods. The results are evaluated based on their respec-
tive calibration models. The weight per cent of the beta
form obtained using the three techniques is listed in
Table 3. The results are all comparable and in good
agreement with the actual weight per cent. For the con-
centrations above 2 wt% of the beta form, all three
techniques were accurate within the experimental error.
For the 0.2–2 wt% range, DSC was consistent. There-
fore, DSC is a powerful technique for qualitative and
content analysis. Using the DSC technique, very low
concentrations can be accurately determined in short run-
times. Because the beta form is hygroscopic, the samples
should be analysed without exposing for a long time.
Due to the sample preparation procedures in PXRD and
DRIFTS being very tedious with greater potential for
exposure and the high limit of detection values for these
techniques, PXRD and DRIFTS are the least preferred
techniques for quantification. Overall, DSC provides the
most accurate predictions.
3.6.  Application  of  the  methodeletriptan, which contained the alpha form contami-
nated with the beta form. All of the batches, which
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Table 2
Accuracy of DSC, PXRD and DRIFTS in the quantitative measurement
of - form in -form.
Actual wt% (Spiked) Calculated wt% %Recovery
DSC
0.3
0.33 110
0.28 93
0.34 113
Mean 0.32
%RSD 10.2
0.6
0.59 98
0.63 105
0.62 103
Mean 0.61
%RSD 3.4
0.9
0.89 99
0.91 101
0.93 103
Mean 0.91
%RSD 2.2
PXRD
3
3.2 107
2.8 93
2.9 97
Mean 2.97
%RSD 7
6
5.8 97
6.1 102
5.9 98
Mean 5.93
%RSD 2.6
9
9.1 101
9.2 102
8.9 99
Mean 9.07
%RSD 1.7
DRIFTS
3
2.7 90
3.3 110
3.4 113
Mean 3.13
%RSD 12.1
6
6.3 105
5.7 95
5.8 97
Mean 5.93
%RSD 5.4
9
8.9 99
8.7 97
9.3 103
Mean 8.97
%RSD 3.4
Table 3
Comparison of DSC, PXRD and DRIFTS results for polymorph mix-
tures of eletriptan.
Actual wt% of
-form
Predicted wt%
by DSC*
Predicted wt%
by PXRD*
Predicted wt%
by DRIFTS*
0 0 0 0
0.4 0.5 Not detected Not detected
4 5 5 6
9 9 9 10
11 11 11 13
14 14 14 15
* Data represents average of three measurements.
Table 4
%-contamination determined in eletriptan -form using three
techniques.
Batch name Concentration of beta form detected
in alpha form (%w/w)
PXRD DSC DRIFTS
B1 Not detected 0.31 Not detected
B2 Not detected 0.43 Not detected
B3 Not detected 0.79 Not detected
B4 Not detected 1.92 Not detected
B5 4.08 3.98 4.21
B6 6.52 6.61 6.74
B7 12.77 12.87 12.9
B8 13.23 13.32 13.44
B9 15.68 15.76 15.83
B10 17.12 17.09 17.19
were labelled B1, B2, B3, B4, B5, B6, B7, B8, B9
and B10, were analysed using the developed and val-
idated methods (i.e., PXRD, DSC and DRIFTS). Due
to the enhanced thermocouple sensitivity of DSC, very
low concentrations of the beta form up to 0.31% were
precisely determined. The results are listed in Table 4.
4.  Conclusion
All three techniques (i.e., DSC, PXRD and DRIFTS)
are applicable for the quantitative measurement of the
polymorphic forms in eletriptan mixtures. DSC pro-
vided more accurate and precise results than PXRD and
DRIFTS. The thermal technique resulted in superior cor-
relation and was accurate for the quantification of the
validation set. DSC is advantageous for both calibration
measurements and routine analysis of large numbers of
samples.
References[1] S. Byrn, R. Pfeiffer, M. Ganey, C. Hoiberg, G. Poochikian,
Pharmaceutical solids: a strategic approach to regulatory con-
siderations, Pharm. Res. 12 (1995) 945–954.
bah Un
[
[
[
[
[
[
[
[
[
[P. Kommavarapu et al. / Journal of Tai
[2] N. Chieng, T. Rades, J. Aaltonen, An overview of recent studies
on the analysis of pharmaceutical polymorphs, J. Pharm. Biomed.
Anal. 55 (2011) 618–644.
[3] A.K. Tiwary, G.M. Panpalia, Influence of crystal habit on
trimethoprim suspension formulation, Pharm. Res. 16 (1999)
261–265.
[4] M.S. Gordonx, Z.T. Chowhan, Manipulation of naproxen particle
morphology via the spherical crystallization technique to achieve
a directly compressible raw material, Drug Dev. Ind. Pharm. 16
(1990) 1279–1290.
[5] D. Singhal, W. Curatolo, Drug polymorphism and dosage form
design: a practical perspective, Adv. Drug Deliv. Rev. 56 (2004)
335–347.
[6] H.G. Brittain, Effects of mechanical processing on phase compo-
sition, J. Pharm. Sci. 91 (2002) 1573–1580.
[7] S.R. Vippagunta, H.G. Brittain, D.J. Grant, Crystalline solids,
Adv. Drug. Deliv. Rev. 48 (2001) 3–26.
[8] J. Bauer, S. Spanton, R. Henry, J. Quick, W. Dziki, W. Porter, J.
Morris, Ritonavir: an extraordinary example of conformational
polymorphism, Pharm. Res. 18 (2001) 859–866.
[9] V. Koradia, G. Chawla, A.K. Bansal, Qualitative and quantita-
tive analysis of clopidogrel bisulfate polymorphs, Acta Pharm.
54 (2004) 193–204.
10] W. Dong, C. Gilmore, G. Barr, C. Dallman, N. Feeder, S. Terry, A
quick method for the quantitative analysis of mixtures. 1. Powder
X-ray diffraction, J. Pharm. Sci. 97 (2008) 2260–2276.
11] G. Dumortier, J.L. Grossiord, F. Agnely, J.C. Chaumeil, A review
of poloxamer 407 pharmaceutical and pharmacological charac-
teristics, Pharm. Res. 23 (2006) 2709–2728.
12] D.E. Bugay, A.W. Newman, W.P. Findlay, Quantitation of
cefepime. 2HCl dihydrate in cefepime. 2HCl monohydrate by
[iversity for Science 9 (2015) 586–593 593
diffuse reflectance IR and powder X-ray diffraction techniques,
J. Pharm. Biomed. Anal. 15 (1996) 49–61.
13] K. Pöllänen, A. Häkkinen, M. Huhtanen, S.-P. Reinikainen,
M. Karjalainen, J. Rantanen, M. Louhi-Kultanen, L. Nys-
tröm, DRIFT-IR for quantitative characterization of polymorphic
composition of sulfathiazole, Anal. Chim. Acta 544 (2005)
108–117.
14] Y. Hu, A. Erxleben, A.G. Ryder, P. McArdle, Quantitative analysis
of sulfathiazole polymorphs in ternary mixtures by attenuated
total reflectance infrared, near-infrared and Raman spectroscopy,
J. Pharm. Biomed. Anal. 53 (2010) 412–420.
15] M. Pelletier, Quantitative analysis using Raman spectrometry,
Appl. Spectrosc. 57 (2003) 20A–42A.
16] D.M. Croker, M.C. Hennigan, A. Maher, Y. Hu, A.G. Ryder, B.K.
Hodnett, A comparative study of the use of powder X-ray diffrac-
tion, Raman and near infrared spectroscopy for quantification of
binary polymorphic mixtures of piracetam, J. Pharm. Biomed.
Anal. 63 (2012) 80–86.
17] E. Watson, M. O’neill, J. Justin, N. Brenner, A differential scan-
ning calorimeter for quantitative differential thermal analysis,
Anal. Chem. 36 (1964) 1233–1238.
18] S. Sweetman (Ed.), The Complete Drug Reference, Thirty fourth
ed., CRC Press, London, 2004.
19] A. Preetam, A.S. Devi, R.M. Sarbajna, M. Suryanarayana, S.
Radhakrishna, K.N. Rao, D. Datta, P.A. Lakshmi, Crystallo-
graphic studies of eletriptan hydrobromide: -form, -form and
its physicochemical characterisation, Mol. Cryst. Liq. Cryst. 570
(2013) 128–147.
20] V.D. Harding, R.J. Macrae, R.J. Ogilvie, Salts of an anti-migraine
indole derivative. U.S. Patent No. 6, 110, 940. 29 August
2000.
